Kedrion’s unrated bond debut welcomed by 155 investors

Kedrion Group, an Italian privately-owned, unrated company, sold its first bond issue on Wednesday, raising €300m from a strong and widely diversified orderbook.
The company, which makes plasma-derived health products for people with haemophilia and immune deficiencies, is a leader in its field. It is family-owned, but Italy’s national investment fund, the Fondo Strategico Italiano, also holds a 19% stake.
Kedrion issued the bond to refinance some of its bank debt ...Already a subscriber? Login